Zentalis Pharmaceuticals Llc
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -151 | -157 | ||
EBITDA | -77,227 | -35,081 | -34,617 | -26,531 |
EBIT | -77,380 | -35,232 | -34,774 | -26,691 |
Net Income | -77,638 | -35,352 | -35,216 | -26,691 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -70,226 | -32,990 | -30,940 | -26,963 |
Cash | 24,783 | 31,930 | 35,995 | 39,072 |
Basic Shares | 70,264 | 70,264 | 71,670 | 72,139 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $67,425 | $0 | $0 |
Gross Profit | -739 | 67,425 | -1,389 | -1,426 |
EBITDA | -144,273 | -186,169 | -247,599 | -233,581 |
EBIT | -145,012 | -187,458 | -248,988 | -235,007 |
Net Income | -137,060 | -165,839 | -292,191 | -236,806 |
Net Change In Cash | 0 | 67,425 | 0 | 0 |
Cost of Revenue | -16,888 | |||
Free Cash Flow | -125,247 | -171,081 | -208,405 | -166,299 |
Cash | 35,995 | 33,901 | 28,038 | 43,069 |
Basic Shares | 71,869 | 71,080 | 65,409 | 52,857 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.59 |
2026-03-31 | -$0.50 |
2025-12-31 | -$0.49 |
2025-09-30 | -$0.37 |